 |
Diabetes
growth doubles in a year |
| |
The number of people diagnosed with diabetes
in the UK has risen by more than 167,000 since last year, bringing
the total diabetes population to almost 2.5 million according to
new data from GP practices (Diabetes UK) |
| |
|
 |
New
Guidelines set to help improve services for adults with diabetes |
| |
Health Minister Edwina Hart has today unveiled
new guidelines that form part of a delivery strategy for the management
of adults with diabetes in Wales (Welsh Assembly Government, UK) |
| |
|
 |
Screening
for type 2 diabetes: A randomised controlled trial in British
general practice |
| |
Screening for type 2 diabetes in primary care
is feasible but may be associated with higher levels of short-term
anxiety among invited compared with non-invited participants (BMC
Public Health) |
| |
|
 |
Surgery
offers best diabetes care in the country |
| |
The practice has received an award from Health
Secretary Alan Johnson after scoring the highest marks nationally
for its service (Salisbury Journal, UK) |
| |
|
 |
Improved
survival in both men and women with diabetes between 1980 and
2004 - a cohort study in Sweden |
| |
Survival rates have improved in subjects with
diabetes since the early 1980s, more so in women than in men, thereby
decreasing the gap to non-diabetic women (Cardiovascular Diabetology
) |
| |
|
 |
Relationship
between beta-cell mass and diabetes onset |
| |
The relative contribution of beta-cell loss
versus beta-cell dysfunction to diabetes onset remains an area
of controversy. However, because cytotoxicity sufficient to induce
beta-cell apoptosis predictably disturbs beta-cell function, it
is naive to attempt to distinguish the relative contributions of
these linked processes to diabetes onset (PubMed) |
| |
|
 |
High
levels of adiponectin reduce the risk of type 2 diabetes in women |
| |
Elevated concentrations of total and high-molecular-weight
adiponectin inversely and strongly correlated with a substantially
reduced risk for diabetes (American Diabetes Association) |
| |
|
 |
Daily
drug helps diabetes patients |
| |
Patients given a daily dose of liraglutide,
a human GLP-1 analogue, achieved better blood glucose control than
those treated with exenatide, a GLP-1 mimetic administered twice
daily (Pharmacy Europe) |
| |
|